Tanaka Capital Management’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
$10.6M Sell
93,184
-18,367
-16% -$2.1M 25.34% 1
2024
Q4
$5.62M Sell
111,551
-585
-0.5% -$29.5K 12.85% 2
2024
Q3
$5.19M Buy
112,136
+11,860
+12% +$549K 12% 2
2024
Q2
$3.26M Buy
100,276
+9,400
+10% +$305K 7.71% 5
2024
Q1
$2.29M Buy
90,876
+53,785
+145% +$1.35M 5.63% 6
2023
Q4
$1.21M Sell
37,091
-478
-1% -$15.5K 2.95% 9
2023
Q3
$1.02M Buy
37,569
+2,030
+6% +$55.3K 2.93% 9
2023
Q2
$791K Hold
35,539
2.14% 13
2023
Q1
$770K Hold
35,539
2.24% 14
2022
Q4
$722K Hold
35,539
2.29% 13
2022
Q3
$911K Hold
35,539
2.72% 11
2022
Q2
$845K Sell
35,539
-3,750
-10% -$89.2K 2.75% 11
2022
Q1
$885K Sell
39,289
-230
-0.6% -$5.18K 1.79% 15
2021
Q4
$782K Sell
39,519
-525
-1% -$10.4K 1.49% 20
2021
Q3
$788K Hold
40,044
1.12% 20
2021
Q2
$881K Hold
40,044
1.19% 16
2021
Q1
$953K Sell
40,044
-110
-0.3% -$2.62K 1.21% 16
2020
Q4
$1.05M Sell
40,154
-160
-0.4% -$4.18K 2.33% 9
2020
Q3
$702K Sell
40,314
-21,540
-35% -$375K 2.2% 14
2020
Q2
$1.04M Sell
61,854
-3,755
-6% -$63.1K 3.22% 11
2020
Q1
$780K Sell
65,609
-4,040
-6% -$48K 3.41% 11
2019
Q4
$843K Sell
69,649
-4,490
-6% -$54.3K 2.67% 12
2019
Q3
$1.05M Sell
74,139
-2,685
-3% -$38K 3.38% 10
2019
Q2
$857K Sell
76,824
-2,750
-3% -$30.7K 2.63% 18
2019
Q1
$934K Sell
79,574
-8,430
-10% -$98.9K 2.82% 14
2018
Q4
$1.18M Sell
88,004
-150
-0.2% -$2K 3.74% 10
2018
Q3
$1.24M Hold
88,154
2.87% 12
2018
Q2
$1.39M Sell
88,154
-56,448
-39% -$888K 3.32% 12
2018
Q1
$2.38M Buy
144,602
+4,320
+3% +$71.1K 5.69% 5
2017
Q4
$2.53M Buy
140,282
+415
+0.3% +$7.49K 5.78% 6
2017
Q3
$2.7M Buy
139,867
+470
+0.3% +$9.07K 6.02% 6
2017
Q2
$1.65M Buy
139,397
+53,692
+63% +$634K 3.77% 10
2017
Q1
$939K Sell
85,705
-1,610
-2% -$17.6K 2.07% 18
2016
Q4
$634K Buy
+87,315
New +$634K 1.48% 23